SEC Info - AbbVie Inc. - ‘8-K’ for 12/31/20

SEC Info℠

Home

Help

Please Sign In

AbbVie Inc. – ‘8-K’ for 12/31/20

On: Wednesday, 1/6/21, at 5:00pm ET · For: 12/31/20 · Accession #: 1104659-21-1570 · File #: 1-35565

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/06/21  AbbVie Inc.                       8-K:5      12/31/20   11:310K                                   Toppan Merrill/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     52K 
 7: R1          Cover                                               HTML     75K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- tm211488d1_8k_htm                   XML     44K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- abbv-20201231_def                XML     87K 
 4: EX-101.LAB  XBRL Labels -- abbv-20201231_lab                     XML    129K 
 5: EX-101.PRE  XBRL Presentations -- abbv-20201231_pre              XML     82K 
 2: EX-101.SCH  XBRL Schema -- abbv-20201231                         XSD     19K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               30±    39K 
11: ZIP         XBRL Zipped Folder -- 0001104659-21-001570-xbrl      Zip     17K

Filing Submission 0001104659-21-001570 – SGML Text

Original SGML Text submitted by:	Toppan Merrill/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 310K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20210106-180050	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20210106-170047	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20210106-170020	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001104659-21-001570
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		13
<PERIOD>			20201231
<ITEMS>				5.02
<FILING-DATE>			20210106
<DATE-OF-FILING-DATE-CHANGE>	20210106

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		AbbVie Inc.
<CIK>				0001551152
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			320375147  ⇒ 32-0375147
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-35565
<FILM-NUMBER>			21511444
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			1 NORTH WAUKEGAN ROAD
<CITY>				NORTH CHICAGO
<STATE>				IL
<ZIP>				60064
<PHONE>				(847) 932-7900
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			1 NORTH WAUKEGAN ROAD
<CITY>				NORTH CHICAGO
<STATE>				IL
<ZIP>				60064
</MAIL-ADDRESS>
</FILER>

<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	tm211488d1_8k.htm
<DESCRIPTION>	FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:abbv="http://abbvie.com/20201231">
       Show <XBRL>: 493 lines (widest: 992 characters) - 46K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.SCH
<SEQUENCE>	2
<FILENAME>	abbv-20201231.xsd
<DESCRIPTION>	XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
       Show <XBRL>: 42 lines (widest: 641 characters) - 6K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.DEF
<SEQUENCE>	3
<FILENAME>	abbv-20201231_def.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 172 lines (widest: 359 characters) - 32K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.LAB
<SEQUENCE>	4
<FILENAME>	abbv-20201231_lab.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 257 lines (widest: 316 characters) - 47K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-101.PRE
<SEQUENCE>	5
<FILENAME>	abbv-20201231_pre.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
       Show <XBRL>: 164 lines (widest: 316 characters) - 30K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	6
<FILENAME>	tm211488d1_8k_htm.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
       Show <XML>: 239 lines (widest: 169 characters) - 16K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	7
<FILENAME>	R1.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 1,389 lines (widest: 430 characters) - 65K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EXCEL
<SEQUENCE>	8
<FILENAME>	Financial_Report.xlsx
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 139 lines (Unix-to-Unix encoding) - 9K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	9  ⇐ Not a Document/Exhibit
<FILENAME>	Show.js
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 5 lines (widest: 296 characters) - 973 bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	10  ⇐ Not a Document/Exhibit
<FILENAME>	report.css
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 182 lines (widest: 57 characters) - 4K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	11  ⇐ Document/Exhibit 9
<FILENAME>	FilingSummary.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
       Show <XML>: 51 lines (widest: 77 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		JSON
<SEQUENCE>	14  ⇒ 12  ⇐ Document/Exhibit 10
<FILENAME>	MetaLinks.json
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 1,618 lines (widest: 521 characters) - 46K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		ZIP
<SEQUENCE>	15  ⇒ 13  ⇐ Document/Exhibit 11
<FILENAME>	0001104659-21-001570-xbrl.zip
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 368 lines (Unix-to-Unix encoding) - 23K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001104659-21-001570 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

AbbVie Inc. – ‘8-K’ for 12/31/20

On: Wednesday, 1/6/21, at 5:00pm ET · For: 12/31/20 · Accession #: 1104659-21-1570 · File #: 1-35565

Previous ‘8-K’: ‘8-K’ on / for 11/18/20 · Next: ‘8-K’ on / for 1/12/21 · Latest: ‘8-K/A’ on 5/8/24 for 2/14/24 · 1 Reference: By: AbbVie Inc. – ‘S-8’ on 5/12/21

Current Report — Form 8-KFiling Table of Contents

Current Report — Form 8-K
Filing Table of Contents